Nipah Virus

Overview of experimental vaccines and antiviral therapeutics for Henipavirus infection.-A Revised Diagnostic Quantitative RT-PCR for Detection of Nipah Virus Infection.- Recombinant Soluble Henipavirus Glycoprotein Preparation.- Cell-cell fusion assays to study henipavirus entry and evaluate therapeutics.- Recombinant Cedar virus: a henipavirus reverse genetics platform.- Utilizing Recombinant Reporter Henipaviruses to Conduct Antiviral Screening.- In vitro antiviral screening for henipaviruses at BSL4.- Isolation of primary porcine bronchial epithelial cells for Nipah virus infections.- Primary culture of the human olfactory neuroepithelium and utilization for henipavirus infection in vitro.- Mouse models of Henipavirus infection.- In vivo imaging of Nipah virus infection in small animal rodent models.- Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation.- Nipah virus aerosol challenge of three distinct particle sizes in nonhuman primates.- Generation and characterization of a humanized lung xenograft mouse model for studying henipavirus pathogenesis.- Ferret models for henipavirus infection.- Syrian golden hamster model for Nipah virus infection.- Anti-Nipah Virus Enzyme-Linked Immunosorbent Assays with Nonhuman Primate and Hamster Serum.- Assays for Detecting Henipavirus Antibodies.- Profiling host microRNA responses to henipavirus infection.- Host Transcriptome Analysis of Ferret Tissues Following Henipavirus Infection.